161 related articles for article (PubMed ID: 15770762)
1. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Pinès E; Zamia P; Idée JM
J Invasive Cardiol; 2005 Feb; 17(2):123-4. PubMed ID: 15770762
[No Abstract] [Full Text] [Related]
2. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Gayet JL; Lefevre T
J Invasive Cardiol; 2005 Feb; 17(2):124. PubMed ID: 15770763
[No Abstract] [Full Text] [Related]
3. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
[TBL] [Abstract][Full Text] [Related]
5. Clinical tolerance and diagnostic efficacy of iobitridol 300 in lower limb angiography.
Stockx L; Wilms G; Baert AL; Terrier F
Acta Radiol Suppl; 1996; 400():72-4. PubMed ID: 8619357
[TBL] [Abstract][Full Text] [Related]
6. [Undesirable side effects of contrast media during i.v. DSA--a comparison of 2 nonionic contrast media].
Gross-Fengels W; Neufang KF; Siebert C; Lanfermann H; Steinbrich W
Rontgenblatter; 1990 Apr; 43(4):144-9. PubMed ID: 2187230
[TBL] [Abstract][Full Text] [Related]
7. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J
Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930
[TBL] [Abstract][Full Text] [Related]
8. [Late adverse reactions of non-ionic intravenous contrast media].
Nambu T; Yoshikawa H; Shirato H; Suzuki K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):1019-21. PubMed ID: 2235336
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of Xenetix, a new iodinated contrast agent, in pediatric angiocardiography.
Rossignol AM; Lusson JR; Chantepie A; Losay J
Acta Radiol Suppl; 1996; 400():81-4. PubMed ID: 8619360
[TBL] [Abstract][Full Text] [Related]
10. [Tolerability of nonionic contrast media--results of a multicenter double blind study].
Schmiedel E
Aktuelle Radiol; 1992 May; 2(3):148-52. PubMed ID: 1610929
[TBL] [Abstract][Full Text] [Related]
11. [The rate of adverse reactions to contrast media after double injections--correlation with the plasma histamine level].
Tschakert H
Rontgenpraxis; 1989 Apr; 42(4):107-11. PubMed ID: 2652339
[No Abstract] [Full Text] [Related]
12. Evaluation of the clinical safety and efficacy of iobitridol (Xenetix) in intravenous urography.
Fournier PJ; Steinbrich W; Freitag P; Voegeli E
Eur J Radiol; 1996 Nov; 23(3):185-9. PubMed ID: 9003922
[TBL] [Abstract][Full Text] [Related]
13. Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT.
Dillman JR; al-Hawary M; Ellis JH; Cohan RH; Kaza R; Myles JD; Khalatbari S; Francis IR
AJR Am J Roentgenol; 2012 Feb; 198(2):392-7. PubMed ID: 22268183
[TBL] [Abstract][Full Text] [Related]
14. [Contrast media in cardiology. Report of a randomized, double-blind multicenter comparative study of the side effects of ionic and non-ionic roentgen contrast media].
Hellige G; Vogel B; Tebbe U; Kreuzer H
Z Kardiol; 1992 May; 81(5):290-2. PubMed ID: 1621410
[No Abstract] [Full Text] [Related]
15. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
Schmiedel E
Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
[TBL] [Abstract][Full Text] [Related]
16. Iobitridol 250 vs iohexol 240 in phlebography of th lower limbs. A double-blind clinical trial.
Chagnaud C; Moulin G; Bartoli JM; Rousseau H; Railhac JJ; Lyonnet D
Acta Radiol Suppl; 1996; 400():89-91. PubMed ID: 8619362
[TBL] [Abstract][Full Text] [Related]
17. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
18. Small-bowel angioedema during screening computed tomography due to intravenous contrast material.
Park SW; Bae IY; Eun HW; Park HW; Choe JW
J Comput Assist Tomogr; 2011; 35(5):549-52. PubMed ID: 21926847
[TBL] [Abstract][Full Text] [Related]
19. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
Sutton AG; Finn P; Grech ED; Hall JA; Stewart MJ; Davies A; de Belder MA
Am Heart J; 2001 Apr; 141(4):677-83. PubMed ID: 11275937
[TBL] [Abstract][Full Text] [Related]
20. Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Anselmino M; Biondi-Zoccai G; Sheiban I
Circulation; 2008 Feb; 117(7):e166; author reply e167. PubMed ID: 18285573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
